C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP-Reference-Cited by-同舟云学术

C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP

Published:2017-06-19 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Carnevale Roberto,Pignatelli Pasquale,Frati Giacomo,Nocella Cristina,Stanzione Rosita,Pastori Daniele,Marchitti Simona,Valenti Valentina,Santulli Maria,Barbato Emanuele,Strisciuglio Teresa,Schirone Leonardo,Vecchione Carmine,Violi Francesco,Volpe Massimo^ORCID,Rubattu Speranza,Sciarretta Sebastiano

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-03679-9.pdf

Reference39 articles.

1. Rubattu, S., Sciarretta, S., Valenti, V., Stanzione, R. & Volpe, M. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens 21, 733–741, doi: 10.1038/ajh.2008.174 (2008).

2. Rubattu, S. et al. Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke 35, 814–818, doi: 10.1161/01.STR.0000119381.52589.AB (2004).

3. Gruchala, M. et al. Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease. Am Heart J 145, 125–131, doi: 10.1067/mhj.2003.52 (2003).

4. Cannone, V. et al. Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study. Hypertension 62, 860–865, doi: 10.1161/HYPERTENSIONAHA.113.01344 (2013).

5. Barbato, E. et al. Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease. J Am Coll Cardiol 59, 1763–1770, doi: 10.1016/j.jacc.2012.02.017 (2012).